Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/10707
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Marija Zdraveska | en_US |
dc.contributor.author | Dejan Todevski | en_US |
dc.contributor.author | Arben Rexhepi | en_US |
dc.contributor.author | Aleksandra Tatabitovska | en_US |
dc.contributor.author | Ismaili, Irfan | en_US |
dc.contributor.author | Slavica Kostadinova-Kunovska | en_US |
dc.contributor.author | Magdalena Bogdanovska-Todorovska | en_US |
dc.contributor.author | Tome Stefanovski | en_US |
dc.contributor.author | Gordana Petrushevska | en_US |
dc.date.accessioned | 2021-03-08T12:11:12Z | - |
dc.date.available | 2021-03-08T12:11:12Z | - |
dc.date.issued | 2019 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/10707 | - |
dc.description.abstract | Lung cancer is the “number one cancer killer” in the world. Its prevalence is associated with smoking as the primary cause, although air pollution in general and genetic factors are also important. The mortality especially from advanced stage lung cancer is still high, although there has been a significant improvement in the past 10 years, mostly due to the introduction of novel compounds such as targeted and immunological treatment. The advances in the treatment of NSCLC have imposed updating of the guidelines for the diagnostic procedure and screening of LC, for the indications for molecular testing as well as for targeted selection of patients who shall benefit the most from the novel treatment modalities. These recommendations shall fulfil their purpose only if implemented in the educational curriculum and if incorporated in the healthcare system strategies. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Македонско лекарско друштво = Macedonian Medical Association | en_US |
dc.relation.ispartof | Македонски медицински преглед = Macedonian Medical Review | en_US |
dc.subject | guidelines | en_US |
dc.subject | non-small cell lung cancer | en_US |
dc.subject | molecular diagnosis | en_US |
dc.subject | diagnostic algorithm | en_US |
dc.title | Consensus statement: RECOMMENDATIONS FOR THE DIAGNOSTIC ALGORITHM IN LUNG CANCER CONSENSUS STATEMENT OF THE MACEDONIAN RESPIRATORY SOCIETY AND THE MACEDONIAN ASSOCIATION OF PATHOLOGY | en_US |
dc.title.alternative | ПРЕПОРАКИ ЗА ДИЈАГНОСТИЧКА ПОСТАПКА КАЈ БЕЛОДРОБЕН КАРЦИНОМ КОНСЕНЗУС НА МАКЕДОНСКОТО РЕСПИРАТОРНО ЗДРУЖЕНИЕ И НА ЗДРУЖЕНИЕТО НА ПАТОЛОЗИ НА МАКЕДОНИЈА – НАДГРАДЕНО ИЗДАНИЕ | en_US |
dc.type | Article | en_US |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
konsenzus za BK MMP 2 2019.doc | 310 kB | Microsoft Word | View/Open |
Page view(s)
156
checked on Jul 11, 2024
Download(s)
54
checked on Jul 11, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.